FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

US conducts strike on another boat carrying suspected narco-traffickers, killing 6 people

Pennsylvania state trooper fatally shot during traffic stop, officials say

Before-and-after satellite imagery offers a rare look at damage inside Iran

Police recover third device in ongoing Manhattan IED investigation after two arrests

Police swarm NYC street Sunday amid IED probe near Gracie Mansion

GOP senators push back against Schumer’s ‘Jim Crow 2.0’ description of SAVE Act

Officials confirm devices recovered at NYC protest near Gracie Mansion were both IEDs

NYPD confirms object thrown at protests near Gracie Mansion in Manhattan was an IED

Pro-Islam counterprotester arrested after deploying explosive device outside Mamdani residence

Trump warns Iran’s new leader won’t ‘last long’ without his approval

Air Force veteran warns ‘cartels don’t collapse — they fracture’ after notorious drug lord killed

The unlikely tool Trump is eyeing to tackle rising oil prices amid the Iran conflict

Trump’s Name Will Be on the Tallest Tower in Australia as Trump’s Company Makes International Real Estate Move

Another ‘Day in the Life’ Video Shows Cushy Conditions at Tech Company

Trump vows block on signing new laws until SAVE America Act passes Senate

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”